In the last reported quarter, U.S. sales of Keytruda were negatively impacted by around $250 million due to the timing of ...

The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of ...

Patients with rheumatoid arthritis who undergo immune checkpoint inhibition for metastatic non-small cell lung cancer demonstrate similar overall survival as those without RA, according to data ...

Merck recently declared a Q4 dividend of $0.81 per share while also securing Health Canada's nod for KEYTRUDA® in cervical ...

The pharmaceutical industry has a fresh sense of direction after President Donald Trump’s tax-and-spending law included a ...

During a live event, Christine Bestvina, MD, discussed trials of KRAS inhibitors plus immunotherapy in patients with ...

Amgen AMGN and Novo Nordisk NVO are among the largest companies in the pharmaceutical space. Amgen boasts one of the largest ...

Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

According to Research by SNS Insider, U.S. Basal Cell Carcinoma Treatment Market Growth is Driven by Aging Population and Technological Advancements in Dermatological Care.Austin, July 23, 2025 (GLOBE ...

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

Cancer researchers at Stanford University and UC San Francisco–now linked through the newly created Weill Cancer Hub ...

Pfizer witnessed a dramatic 45.77% surge in trading volume, reaching a staggering 11.97 billion shares. Pfizer's stock price ...